Topical ALA photodynamic therapy: Began Phase II trials

DUSA Pharmaceuticals Inc. (DUSA), Toronto Product: Topical ALA photodynamic therapy Indication: Superficial basal cell carcinomas Status: Began Phase II trials in 60 patients. Because previous studie...